Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-020730
Filing Date
2021-11-18
Accepted
2021-11-18 13:00:36
Documents
1
Period of Report
2021-11-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 3607
  Complete submission text file 0001567619-21-020730.txt   5356
Mailing Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103 415-448-6534
EcoR1 Capital, LLC (Reporting) CIK: 0001587114 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38318 | Film No.: 211423565

Mailing Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016 332-206-0935
Odonate Therapeutics, Inc. (Issuer) CIK: 0001717452 (see all company filings)

EIN.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations